Effects of Radix Astragali on Angiotensin-converting Enzyme 2 Expressions in Kidney in Renal Hypertensive Rats

YANG Li-li,YU Jing,CHANG Peng
DOI: https://doi.org/10.3969/j.issn.1673-7245.2007.01.012
2007-01-01
Abstract:Objective To determine the expressions of angiotensin-converting enzyme 2(ACE2) in two-kidney and one-clip(2K1C) hypertensive rats and the effect of Radix Astragali. Methods Fifty adult male Wistar rats were groupped as follows: control group(n=10), 2K1C renal hypertension group(n=10), 2K1C+high dose Radix Astragali group ; 2K1C+low dose Radix Astragali group(10 g/kg·d, n=10), 2K1C+ valsartan group (20 g/kg·d, n=10) for 8 weeks. The levels of mRNA expression of ACE2 was determined by RT-PCR and the distribution and expression of ACE2 in kidney by immunohistochemistry. Renal Ang Ⅱ was measured with radioimmunoassay. SBP were measured by tail-cuff method. Results ACE2 mRNA in kidney were found to be significantly decreased in the 2K1C hypertensive rats compared with those of the control group (0.282±0.025 vs 0.359±0.017, P<0.05). Radix Astragali and valsartan treatment increased ACE2 mRNA (0.398±0.004, 0.391±0.006 vs control: 0.403±0.009, P<0.05). Both Radix Astragali and valsartan decreased BP significantly(P<0.01), however high dose Radix Astragali decreased renal Ang Ⅱ more markedly than those by valsartan (P<0.01). Conclusion The renal ACE2 is down-regulated and the level of Ang Ⅱ is increased in 2K1C group. Radix Astragali and valsartan increase ACE2 in renal tissue along with BP decreases.
What problem does this paper attempt to address?